Carregant...
Therapeutic drug monitoring of infliximab in spondyloarthritis. A review of the literature
Available evidence indicates that a therapeutic drug monitoring strategy leads to major cost savings related to the anti‐tumour necrosis factor‐α therapy in both inflammatory bowel disease and rheumatoid arthritis (RA) patients, with no negative impact on efficacy. However, although the systematic u...
Guardat en:
| Publicat a: | Br J Clin Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783598/ https://ncbi.nlm.nih.gov/pubmed/31315147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14062 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|